Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-16-034087)

Filing Details

Accession Number:: 0001225208-16-034087
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-05-27 11:03:27
Reporting Period:: 2016-05-26

Filing Date:: 2016-05-27
Accepted Time:: 2016-05-27 11:03:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1194004	A Frank Damelio	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-05-26	100,000	$24.43	472,994	No	4	M	Direct
Common Stock	Disposition	2016-05-26	2,400	$34.47	470,594	No	4	S	Direct
Common Stock	Disposition	2016-05-26	4,663	$34.48	465,931	No	4	S	Direct
Common Stock	Disposition	2016-05-26	20,999	$34.50	444,932	No	4	S	Direct
Common Stock	Disposition	2016-05-26	71,938	$34.49	372,994	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2016-05-26	100,000	$0.00	100,000	$24.43

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2017-09-27	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,705	Indirect	By Rule 16b-3 Plan

Footnotes

These options are fully exercisable.